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Dear Sir, there is increasing evidencethat systemic infections playarole in the pathogenesis of cardiovascularo rc erebrovasculard isorders (1) . Theincidence of myocardialinfarction and strokeincreases during acute infections (2) ,and several viral (3) and bacterial (4) infections are positive risk factorsinsusceptible individuals. Epidemiological, aetiological and/or laboratorystudies have provided supportfor alink between infectious agents such as CoxsackieB (5), influenza ( 6) , Chlamydia pneumoniae (7) , Helicobacter pylori (8) and orally-derivedinfections (9, 10) , and the incidenceofcoronary artery disease. Streptococcus sanguis is an oralorganism whichhas been isolatedfrom the circulation of individualsfollowing dentalextractions (11) and from atherosclerotic plaques ( 12) . Consequently, plateleta ctivation by S. sanguis has beenpostulatedtoprovide the link between periodontalinfections and atherothrombotic conditions (13) .
S. sanguis inducesp lateleta ggregation both in vitro and in vivo in astrain-and donor-dependent manner (14) . Herzberget al.h avep artiallyc haracterised the S. sanguis/plateleti nteraction, usingprimarily strain 2017-78, and suggest thatplateletactivating strains of S. sanguis express aprotein,termedP AAP, withhomology to collagen (15) . Platelet activation by S. sanguis strain 2017-78 is also dependent upon the interaction of IgG with its lowaffinity plateletreceptor,Fc γ RIIA, in athromboxane A 2 -mediated manner (16, 17) . There is aconcentration-dependent relationshipb etween IgGb indingt o S. sanguis strain 2017-78 and the induction of aggregation, whichinsome, but not all, individuals accounts for the responsiveness of their platelets to the bacteria (18) .Incontrast, polymorphic variation in Fcγ RIIA does notdetermine donor response to S.sanguis (18) . Other inherent propertiesofplatelets or plasma maycontribute to the variability in donor response.
One plausible contributor to donor variability thath as not beenconsideredpreviouslyisvon Willebrand factor (vWF). This largemultimeric glycoprotein (GP) promotes plateletadhesion at sites of vasculardamage and stabilizesplatelet-plateletinteractions via interactionsw ith collagena nd with both the GPIb/ V/IX and α IIb β 3 receptors on the plateletsurface. Giventhe structuralhomology betweenPAAP and collagen, and thecapacity for collagentobind to vWF, arole for vWF is possible. In the current study ar ole for vWF in donor/strain-dependent S. sanguis-inducedplateletactivation wasexamined.
Platelet aggregation in platelet-rich plasma(PRP) wasdeterminedbylight transmission in response to three strains of S. sanguis, 2017-78, SK108a and SK112(platelet:bacteria ratio of 1:2 [17] ), in addition to the thrombin receptor activating peptide (TRAP;SFLLRN; 10 µM). The platelets of all donors (n=8) aggregated when challengedwith either S. sanguis strain 2017-78 or the soluble agonist TRAP.I nc ontrast, S. sanguis strain SK108a caused the aggregation of platelets in fourofeight donors, while S. sanguis strainS K112 failedt op roduce aggregation in anyofthe donors (Table 1) . These data areconsistent with apreviousreport thatstrains 2017-78and SK112 are"aggregating" and "non-aggregating" strains,respectively, whereas strain SK108a produces variable responses (18) .
Platelets were suspended in homotypic vWF-depleted plasma (cryosupernatants) prepared by afreeze/slow-thawtechnique (19)yielding vWFantigen levels of <0.10 U/ml in sevenofeight donorsand of 0.35 U/ml in the final donor ( Table 1 ). The levels of IgG binding to S. sanguis strain2017-78 were measured and aggregation determined, as previously reported (17, 18) . The levelofIgG binding wassimilarinPRP (20.3 ±1.5 µg IgG/mg bacteria; mean±SEM, n=8) and cryosupernatants(20.6 ±2.7 µg IgG/mg bacteria; mean±SEM, n=8),and thus therewas no loss of 2017-78-specificIgG during cryoprecipitation. In all individuals, plateleta ggregation in response to S. sanguis strain 2017-78 wasabolished (Table 1) . Similarly,plateletaggregation in cryosupernatantsw as absent in response to S. sanguis strain SK108a,regardless of whether aggregation hadoccurred in PRP. No platelet aggregation wasobservedinresponseto S. sanguis strain SK112 in cryosupernatants, whereas normal responses to TRAPwere retained in alldonors ( Table 1) .
The platelets of atype 3von Willebrand disease(vWD)patient were examined. This 19-year-old womanofHispanic origin hasaclinical historyo fr ecurrente pistaxis, menorrhagia and haemarthrosis. Laboratoryfindings includedF VIII activity of 0.05U/ml, vWFantigen of 0.02U/ml and undetectablelevelsof vWF ristocetin co-factor.The PRPfrom the vWDpatient aggregatedi nr esponset oTRAPc onfirming that her platelets were functionallya ctive, butd id not respondt o S. sanguis strains 2017-78, SK108a or SK112. Whent he platelets of an ormal donor,which responded to S. sanguis strain 2017-78 and TRAP in PRP, were resuspended in vWDpatient plasma theyretained responsivenesst oTRAPb ut not to S. sanguis strain 2017-78. Thus the vWD plasma could supportplateletaggregation to soluble agonists butnot to the S. sanguis,confirming that aplasma component, absent fromthe vWD plasma, is essential for S. sanguis-inducedplateletactivation.
Previousstudiesexamining potential rolesofvWF and GPIb using others trains of S. sanguis have beeni nconclusive.F or exampleb oth Ford et al. and Kerrigan et al., using strains NCTC7863 and 133-79,r espectively, demonstrated that antiGPIb antibodies inhibited plateletaggregation butinavWF independent manner (20, 21) . Arole for GPIb wasapparentlysupported in the latter study where plateletsfrom aBernard-Soulier patient did not respond to strain 133-79. This contradicted apreviousstudy where strains 133-79and 2017-78 caused the aggregation of Bernard-Soulierplatelets (22).
Therole of vWF in S. sanguis strain 2017-78-induced platelet activation remains speculative.S everal studiesh avep roposed that2017-78 employs a"collagen-like" mechanism, suggesting that 2017-78 interacts with vWF in amanner similar to collageninducing aconformational change in vWF,promoting its interaction with GPIba nd therebyi nitiating plateleta ggregation. Sucham echanism hasb een proposed forp lateleta ctivation in response to Staphylococcus aureus (23) .Asecond possibilityi st hat IgG,a lready shown to be importanti n 2017-78-induced aggregation, activatesplatelets and causes the conformationalc hange in the α IIb β 3 integrin, allowingv WF binding to the plateletand consolidating aggregation. Although this scenario is possible,itisunclear why S. sanguis would be uniquelydependentonvWF forthis function. Athird possibility is thatvWF serves to facilitate the interaction of S. sanguis with platelets, specificallyatthe levelofthe IgG and Fcγ RIIA. Interestingly, Kerrigan et al.suggestedthat 133-79-induced platelet activation is Fcγ RIIA-dependent buto ccursi nt he absence of plasma proteins, including IgG (21) .
Regardless of the mechanism, the currents tudy demonstrates thatv WF is involved in 2017-78-induced aggregation. Clearlythereisconsiderableinter-strain variability as 2017-78 and 133-79 do nota ppeart os harem echanisms of activation. Furthermore,itispossible that alterations, or polymorphisms, in either vWF or its receptor (GPIb) mayaccount forthe observed donor variability and mayimpact upon the susceptibility of patients with periodontaldiseasetoarterial thrombosis (9, 10).
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